Professional Conferences Held as Part of Cryo-Save's Cord Blood Awareness Months

Zutphen, The Netherlands (ots/PRNewswire) -

Cryo-Save Group promotes the awareness of cord blood storage and
stem cell therapies at several professional conferences held
throughout eastern and southern Europe.

It is with great pleasure that Cryo-Save supports the awareness,
research and advancement of cord blood storage and therapies by
taking part in and sponsoring four major conferences in Cyprus,
Bosnia-Herzegovina, Serbia and Hungary during the months of September
and October.

Stem cells are becoming ever more important in the medical field
as a way to treat a broad variety of malignant and non-malignant
diseases such as leukemia's and other childhood cancers. Patients
suffering from sickle cell anemia have been considered cured after
being treated with stem cells.[1] Over 4,000 clinical trials using
cord blood stem cells are taking place to treat diseases such as
cerebral palsy, diabetes and autism with many more potential clinical
trials continuing to develop.

"Cryo-Save's efforts to inform the medical community about
advances in regenerative medicine means that patients suffering from
diseases treatable with stem cells can also become better informed,"
says Dr. Cherie Daly, Medical Affairs Manager Cryo-Save. "Having a
series of events and programs as part of Cord Blood Awareness Months
makes an even stronger impact on the meaningfulness of this research
and its application." Cryo-Save Group will continue its commitment to
promoting the storage of cord blood and stem cells even after Cord
Blood Awareness Months by offering several customer related
promotions.

A half-day conference in Limassol, Cyprus will be held September
15 giving the medical community the opportunity to talk with
scientists specialized in stem cells about the latest applications
and cord blood and tissue regulatory requirements. Cryo-Save's
Medical Affairs Manager Dr. Cherie Daly, member of ITERA
(International Tissue Engineering Research Association), member of
the Advisory Panel for the Parents' Guide to Cord Blood Foundation
and Dr. Sally Sennitt, Cryo-Save Lab Director, will be there to
present on these topics.

The third International Conference on Regenerative Medicine: Stem
Cells, Genetic Engineering and Biotechnologies will take place
September 21 in Banja Luka, Bosnia and Herzegovina. Arnoud van
Tulder, Cryo-Save Group CEO, will present on the "Importance of
Family Stem Cell Banking: Over 10 Years of Leading Experience."
Medical professionals will also present on subjects like applications
of cord blood, stem cell therapies and pharmacogenomics.

--------------------------------------------------

1. University of Illinois at Chicago (2012, June 18). Chicago
woman cured of sickle cell disease. ScienceDaily. Retrieved September
12, 2012, from
http://www.sciencedaily.com/releases/2012/06/120618194714.htm

With the idea of broadening perspectives and expanding knowledge
in the areas of regenerative medicine, genetics and clinical
applications, Cryo-Save Serbia will be sponsoring the fifth
International Symposium on Regenerative and Personalised Medicine on
October 4 in Belgrade. Leading speakers such as Prof. Dr. Daniel
Surbek from the University of Bern, Switzerland and Maja Stojiljkovic
Petrovic, PhD of IMGGE, University of Belgrade will present their
research and other works pertaining to stem cell application in
tissue engineering at the symposium.

Sejtbank, Cryo-Save's subsidiary in Hungary, will be sponsoring
the From Birth to Three Years of Age International Professional
Conference in Budapest, October 29-31. The conference focuses on
early intervention for children in need, explores international
experiences and research results, presents domestic and special
regional practices along with specifically Hungarian forms of
therapy. Dr. Cherie Daly, Cryo-Save Medical Affairs Manager will
present on "The Role of Umbilical Cord Blood in Neonatal and
Pediatric Care".

Cryo-Save, the leading international family stem cell bank, and
the largest bank in Europe, stores more than 222,000 samples from
umbilical cord blood, cord tissue and adipose tissue. There are
already many diseases treatable by the use of stem cells, and the
number of treatments will only increase. Driven by its international
business strategy, Cryo-Save is now represented in over 40 countries
on three continents, with ultra-modern processing and storage
facilities in Arabia, Belgium, Germany, India and South Africa.

Cryo-Save: http://www.cryo-save.com/group

ots Originaltext: Cryo-Save AG
Im Internet recherchierbar: http://www.presseportal.de

Contact:
More information: Ashley Ringger - Marketing Project Manager,
ashley.ringger@cryo-save.com, tel: +41-55-222-0251